{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=19", "query": { "intervention": "Capsule 2", "page": 19 }, "page_size": 10 }, "pagination": { "page": 19, "page_size": 10, "total_count": 5051, "total_pages": 506, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=20&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Capsule+2&page=18&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T03:01:13.784Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00005044", "title": "Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Casodex", "type": "DRUG" }, { "name": "Eulexin", "type": "DRUG" }, { "name": "LHRH agonist", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Radiation Therapy Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "18 Years to 120 Years · Male only" }, "enrollment_count": 1579, "start_date": "2000-02", "completion_date": "2022-05-20", "has_results": true, "last_update_posted_date": "2022-06-15", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 241, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 181 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005044" }, { "nct_id": "NCT01069965", "title": "Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus" ], "interventions": [ { "name": "BGP-15 100 mg QD", "type": "DRUG" }, { "name": "BGP-15 100 mg BID", "type": "DRUG" }, { "name": "Placebo BID", "type": "DRUG" }, { "name": "BGP-15 200 mg QD", "type": "DRUG" }, { "name": "BGP-15 200 mg BID", "type": "DRUG" }, { "name": "BGP-15 400 mg QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "N-Gene Research Laboratories, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 196, "start_date": "2010-10", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2014-09-29", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 20, "location_summary": "Los Angeles, California • Paramount, California • Tustin, California + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Tustin", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01069965" }, { "nct_id": "NCT02626299", "title": "Assessment of DHA On Reducing Early Preterm Birth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Preterm Birth" ], "interventions": [ { "name": "Docosahexaenoic acid - 800mg/day", "type": "DRUG" }, { "name": "Docosahexaenoic acid - 200mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1100, "start_date": "2016-06-08", "completion_date": "2020-10-05", "has_results": false, "last_update_posted_date": "2021-03-30", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 3, "location_summary": "Kansas City, Kansas • Cincinnati, Ohio • Columbus, Ohio", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02626299" }, { "nct_id": "NCT01248130", "title": "Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder (ASD)" ], "interventions": [ { "name": "Omega-3 Fatty Acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 7, "start_date": "2009-11", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2025-03-27", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01248130" }, { "nct_id": "NCT03161964", "title": "Propranolol in Treating Hypoglycemia Unawareness", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Propranolol 80 Mg Oral Capsule, Extended Release", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anu Sharma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "21 Years to 59 Years" }, "enrollment_count": 2, "start_date": "2017-10-19", "completion_date": "2019-12-19", "has_results": true, "last_update_posted_date": "2020-08-24", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03161964" }, { "nct_id": "NCT01272830", "title": "Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Edematous", "Synovitis", "Foreign Body Reaction", "Osteolysis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Apatone®B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "IC-MedTech Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 57, "start_date": "2010-10", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2018-01-31", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 1, "location_summary": "Akron, Ohio", "locations": [ { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01272830" }, { "nct_id": "NCT05826912", "title": "Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Traumatic Brain Injury" ], "interventions": [ { "name": "Atorvastatin Calcium", "type": "DRUG" }, { "name": "Minocycline Hydrochloride", "type": "DRUG" }, { "name": "Candesartan Cilexetil", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 672, "start_date": "2024-08-01", "completion_date": "2029-08-31", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 18, "location_summary": "San Francisco, California • Indianapolis, Indiana • Lexington, Kentucky + 14 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05826912" }, { "nct_id": "NCT05545319", "title": "A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "Coronavirus Disease 2019 (COVID-19)", "Immunocompromised", "Hospitalization", "Child, Hospitalized" ], "interventions": [ { "name": "Nirmatrelvir", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Placebo for nirmatrelvir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": "2022-12-13", "completion_date": "2024-01-06", "has_results": false, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 2, "location_summary": "Cooperstown, New York • New York, New York", "locations": [ { "city": "Cooperstown", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05545319" }, { "nct_id": "NCT05484401", "title": "Ibuprofen Liquid Capsules 2 x 200 mg Efficacy and PK/PD Study in Surgical Removal of Impacted Third Molars", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tooth, Impacted", "Tooth Diseases", "Stomatognathic Diseases" ], "interventions": [ { "name": "Ibuprofen 200Mg Oral Cap", "type": "DRUG" }, { "name": "Ibuprofen 200Mg Oral Tablet", "type": "DRUG" }, { "name": "Placebo Liquid Capsule", "type": "OTHER" }, { "name": "Placebo Tablets", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Reckitt Benckiser Healthcare (UK) Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "16 Years to 55 Years" }, "enrollment_count": 294, "start_date": "2022-08-09", "completion_date": "2023-06-15", "has_results": false, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05484401" }, { "nct_id": "NCT04018300", "title": "Iron Supplementation and Side Effects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Iron Deficiency Anemia", "Iron Overload" ], "interventions": [ { "name": "Ferrous sulfate", "type": "DIETARY_SUPPLEMENT" }, { "name": "Aspiron", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Iowa State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "18 Years to 40 Years · Female only" }, "enrollment_count": 17, "start_date": "2018-01-08", "completion_date": "2018-04-18", "has_results": false, "last_update_posted_date": "2019-07-12", "last_synced_at": "2026-10-31T03:01:13.784Z", "location_count": 1, "location_summary": "Ames, Iowa", "locations": [ { "city": "Ames", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04018300" } ] }